Insider · CIK 0001349376

Walbert Timothy P

Reports to the SEC for 17 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001349376

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	KARDKardigan, Inc.A Award	Director	AAward	+20.7K sh	—	—	20,706
2026-06-17	KARDKardigan, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+57.6K sh	—	—	57,573
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-02	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,490 sh	—	—	17,270
2026-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,977 sh	—	—	9,680
2026-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,977 sh	—	—	0
2026-05-07	ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,393
2025-06-12	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2025-06-09	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.3K sh	—	—	32,250
2025-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,703 sh	—	—	5,703
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,703 sh	—	—	0
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-20	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+6,650 sh	—	—	9,780
2025-02-24	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,130 sh	—	—	3,130
2024-06-20	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,779 sh	—	—	8,779
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,703 sh	—	—	5,703
2024-06-05	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,279 sh	—	—	9,279
2024-04-01	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+73K sh	—	—	73,014
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−617K sh	$116.50	−$71.9M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−108K sh	$116.50	−$12.6M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−100K sh	$116.50	−$11.7M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−49.9K sh	$116.50	−$5.82M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−743K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−1.65M sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−34.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−49.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−71.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−45.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−17.4K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−105K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−14.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−44.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−73.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−35.6K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−17.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−17.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−4,657 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−14.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−20.7K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−21.4K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−12.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−4,285 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−10.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−5,174 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	Director, Chairman, President and CEO	DDisposition to Issuer	−5,174 sh	—	—	0
2023-06-27	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-06-12	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,417 sh	—	—	1,417

Recent filings

Accepted (ET)
Jun 224
Walbert Timothy P0001193125-26-277918
SEC(opens sec.gov)
Jun 174
Walbert Timothy P0001349376-26-000004
SEC(opens sec.gov)
Jun 44
Walbert Timothy P0001628280-26-040920
SEC(opens sec.gov)
Jun 24
Walbert Timothy P0001349376-26-000002
SEC(opens sec.gov)
May 114
Walbert Timothy P0001193125-26-217586
SEC(opens sec.gov)
Jun 164
Walbert Timothy P0001062993-25-011782
SEC(opens sec.gov)
Jun 104
Walbert Timothy P0001104659-25-058226
SEC(opens sec.gov)
Jun 24
Walbert Timothy P0001415889-25-015299
SEC(opens sec.gov)
May 224
Walbert Timothy P0001048477-25-000078
SEC(opens sec.gov)
Feb 264
Walbert Timothy P0001048477-25-000013
SEC(opens sec.gov)
Jun 214
Walbert Timothy P0001062993-24-012906
SEC(opens sec.gov)
Jun 74
Walbert Timothy P0001415889-24-016070
SEC(opens sec.gov)
Jun 74
Walbert Timothy P0001104659-24-069639
SEC(opens sec.gov)

Companies

Address

C/O LATIGO BIOTHERAPEUTICS, INC. 1300 RANCHO CONEJO BLVD., SUITE 305

THOUSAND OAKS, CA, 91320